Back to News
Market Impact: 0.2
BTIG Initiates Coverage of DarioHealth with Buy Rating
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
BTIG initiated coverage of DarioHealth on October 27, 2026, with a Buy recommendation. The stock’s latest stated close was $3.77 on October 23, 2026, matching its pre-action close; the article provides no subsequent share-price reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
DRIO0.45
More News
- What investors need to know about Alphabet's stock-busting earnings report
- FedEx's soft holiday-quarter outlook doesn't change our view on the stock
- Breaking Down Alphabet's Disappointing Earnings Report
- Bond investor Jeff Gundlach talks to CNBC about Fed's rate pause, Warsh reducing vote-setting meetings
- Bausch Health raises 2026 outlook as third-quarter adjusted earnings surge 53%
- Mizuho reiterates American Electric Power stock rating at Neutral
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- Augmented Intelligence: AllMind, Elevate Human Judgement With an Accessible, Powerful, Data-Driven Financial AI Toolkit
- Choosing an AI Copilot for Equity Research